These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21038716)
1. Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. Wkly Epidemiol Rec; 2010 Oct; 85(43):434-6. PubMed ID: 21038716 [No Abstract] [Full Text] [Related]
2. Pneumococcal serotypes in the elderly. Kellner JD; Mandell L Clin Infect Dis; 2005 Aug; 41(4):488-9. PubMed ID: 16028156 [No Abstract] [Full Text] [Related]
3. Understanding the link between pneumococcal serotypes and invasive disease. Soley C; Arguedas A Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183 [TBL] [Abstract][Full Text] [Related]
4. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Rodgers GL; Arguedas A; Cohen R; Dagan R Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378 [TBL] [Abstract][Full Text] [Related]
5. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?]. Moraga-Llop FA Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995 [No Abstract] [Full Text] [Related]
6. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ; McIntosh ED; Reinert RR Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359 [TBL] [Abstract][Full Text] [Related]
7. Emergence of Streptococcus pneumoniae serotype 15A after the introduction of the conjugate vaccine in Victoria. Strachan JE; Rowe SL; Dunne EM; Hogg GG Med J Aust; 2013 Oct; 199(7):461-3. PubMed ID: 24099202 [No Abstract] [Full Text] [Related]
8. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG; JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418 [TBL] [Abstract][Full Text] [Related]
10. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines. McElligott M; Vickers I; Cafferkey M; Cunney R; Humphreys H Vaccine; 2014 Jun; 32(28):3495-500. PubMed ID: 24795223 [TBL] [Abstract][Full Text] [Related]
13. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Prymula R Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951 [TBL] [Abstract][Full Text] [Related]
14. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Zangeneh TT; Baracco G; Al-Tawfiq JA Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802 [TBL] [Abstract][Full Text] [Related]
15. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773 [TBL] [Abstract][Full Text] [Related]
16. Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971-2004) and serotype coverage by marketed pneumococcal vaccines. Akduman D; Ehret JM; Judson FN Clin Microbiol Infect; 2006 Nov; 12(11):1141-3. PubMed ID: 17002617 [TBL] [Abstract][Full Text] [Related]
17. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454 [TBL] [Abstract][Full Text] [Related]
18. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
19. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717 [TBL] [Abstract][Full Text] [Related]
20. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region. Pelton SI Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351 [No Abstract] [Full Text] [Related] [Next] [New Search]